2,509 Shares in CME Group (NASDAQ:CME) Purchased by HPM Partners LLC

HPM Partners LLC acquired a new stake in CME Group (NASDAQ:CME) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 2,509 shares of the financial services provider’s stock, valued at approximately $366,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of CME. Raymond James Financial Services Advisors Inc. lifted its position in CME Group by 7.6% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 369,133 shares of the financial services provider’s stock valued at $50,090,000 after acquiring an additional 26,047 shares in the last quarter. Candriam Luxembourg S.C.A. lifted its position in CME Group by 4.9% in the 3rd quarter. Candriam Luxembourg S.C.A. now owns 23,717 shares of the financial services provider’s stock valued at $3,218,000 after acquiring an additional 1,107 shares in the last quarter. Global X MANAGEMENT CO LLC lifted its position in CME Group by 7.9% in the 3rd quarter. Global X MANAGEMENT CO LLC now owns 7,626 shares of the financial services provider’s stock valued at $1,035,000 after acquiring an additional 559 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. lifted its position in CME Group by 1,095.2% in the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 168,712 shares of the financial services provider’s stock valued at $22,891,000 after acquiring an additional 154,596 shares in the last quarter. Finally, Advisor Group Inc. lifted its position in CME Group by 6.6% in the 3rd quarter. Advisor Group Inc. now owns 23,178 shares of the financial services provider’s stock valued at $3,143,000 after acquiring an additional 1,429 shares in the last quarter. 83.11% of the stock is currently owned by institutional investors and hedge funds.

How to Become a New Pot Stock Millionaire

In related news, Chairman Terrence A. Duffy sold 20,000 shares of the company’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total value of $3,033,200.00. Following the transaction, the chairman now owns 99,239 shares in the company, valued at approximately $15,050,586.74. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO John W. Pietrowicz sold 7,500 shares of the company’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the completion of the transaction, the chief financial officer now owns 32,376 shares in the company, valued at approximately $4,904,964. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 40,699 shares of company stock worth $6,266,062. 0.57% of the stock is owned by insiders.

Several equities research analysts recently commented on CME shares. Goldman Sachs raised shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price objective on the stock in a research report on Wednesday, February 7th. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research report on Tuesday, January 9th. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target on the stock in a research report on Tuesday, January 2nd. Bank of America boosted their price target on shares of CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a research report on Friday, February 2nd. Finally, Sandler O’Neill reissued a “buy” rating and set a $175.00 price target on shares of CME Group in a research report on Friday, February 2nd. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. CME Group currently has a consensus rating of “Buy” and an average price target of $163.69.

Shares of CME stock opened at $158.26 on Friday. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $54,628.39, a PE ratio of 33.18, a PEG ratio of 2.27 and a beta of 0.56. CME Group has a 52-week low of $114.82 and a 52-week high of $171.71.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.02. The company had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. CME Group’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.14 EPS. equities analysts forecast that CME Group will post 6.72 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.77%. This is a boost from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Thursday, March 8th. CME Group’s dividend payout ratio is presently 58.70%.

COPYRIGHT VIOLATION WARNING: This news story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/04/07/hpm-partners-llc-invests-366000-in-cme-group-inc-cme.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply